Home › Funds › Royce & Associates › ACAD
Royce & Associates position in ACAD
ACADIA PHARMACEUTICALS INC · Health Care
Latest position (Q2 2026)91.89K sh
Reported value held$2.32M
Portfolio Weight0.02%
First reportedQ2 2026
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 91.89K | $2.32M | New |
Other funds holding ACAD
- BlackRock Inc 22.52M sh · $569.63M · Q2 2026
- Vanguard Group 15.15M sh · $404.76M · Q4 2025
- Geode Capital Management 3.36M sh · $84.98M · Q2 2026
- Goldman Sachs Group 2.58M sh · $65.28M · Q2 2026
- Arrowstreet Capital 1.97M sh · $49.83M · Q2 2026
- Marshall Wace 1.76M sh · $44.65M · Q2 2026
- D. E. Shaw & Co 1.70M sh · $42.96M · Q2 2026
- Norges Bank Investment Management 1.62M sh · $41.07M · Q2 2026
- Northern Trust Corp 1.37M sh · $34.60M · Q2 2026
- Bank of America Corp 1.30M sh · $32.90M · Q2 2026
- Renaissance Technologies 1.28M sh · $32.45M · Q2 2026
- Charles Schwab Investment Management 1.21M sh · $30.52M · Q2 2026